Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Honorees Announced in ASDSA’s 2020 Top Advocate Program


Top Advocates have gone above and beyond in advocating for patient safety and the field of dermatologic surgery. We greatly appreciate their efforts, particularly this year when physicians have faced extraordinary challenges to continue to keep their practices viable during the COVID-19 pandemic.

The American Society for Dermatologic Surgery Association (ASDSA) is proud to announce the honorees in its annual Top Advocate program this week during the ASDS / ASDSA Annual Meeting. Honorees were selected based on their participation in various advocacy events in 2020 and demonstrated dedication to patient safety and the field of dermatologic surgery.

2020 ASDSA Top Advocates:

  • M. Laurin Council, MD (St. Louis, MO)
  • Sue Ellen Cox, MD (Chapel Hill, NC)
  • Terrence Cronin, Jr., MD (Melbourne, FL)
  • Seemal Desai, MD (Plano, TX)
  • Alexander Gross, MD (Cumming, GA)
  • Sara Hogan, MD (Long Beach, CA)
  • Basia Michalski, MD (St. Louis, MO)
  • Kelly Park, MD (Hines, IL)
  • Kelley Redbord, MD (Vienna, VA)
  • Anthony Rossi, MD (New York, NY)

2020 ASDSA Top Advocates – Honorable Mention, Gold:

  • Catherine DiGiorgio, MD (Boston, MA)
  • Michael Graves, MD (Austin, TX)
  • Deirdre Hooper, MD (New Orleans, LA)
  • Rachel Kyllo, MD (Arnold, MO)
  • Jason Neustadter, MD (Philadelphia, PA)
  • James Tidwell, MD (Mission Viejo, CA)
  • Abigail Waldman, MD (Boston, MA)

2020 ASDSA Top Advocates – Honorable Mention, Silver:

  • Nicholas Golda, MD (Columbia, MO)
  • Hayley Goldbach, MD (Los Angeles, CA)
  • Vineet Mishra, MD (San Diego, CA)

“ASDSA’s members are critical to its mission of speaking in a united voice to promote, protect and advance surgical and cosmetic dermatology though education and advocacy. Top Advocates have gone above and beyond in advocating for patient safety and the field of dermatologic surgery,” said ASDSA President Marc D. Brown, MD. “We greatly appreciate the efforts of these members, particularly this year when physicians have faced extraordinary challenges to continue to keep their practices viable during the COVID-19 pandemic.”

# # #

About ASDSA

With a membership of 6,400+ physicians, ASDSA is a 501(c) (6) association, dedicated to education and advocacy on behalf of dermatologic surgeons and their patients. For more information, visit http://asds.net/ASDSA.

Follow @ASDSAdvocacy on Facebook, Twitter, Instagram and LinkedIn!

Share article on social media or email:



Ultra-Comfortable and Eco-Friendly Baby Nappies Are Introduced by Melu Monkey Which Initiates A Powerful Crowdfunding Campaign


Wet Sensor and Elasticated Waist Band

‘By becoming more mindful of our daily habits and making environmentally aware choices, we can make a difference’ Sir David Attenborough

Nappies play a significant role in taking care of a baby, and parents know that well. The UK disposes of around 3 billion disposable nappies each year, representing an estimated 2% to 3% of all household waste. By the time one baby is potty trained, the baby could use 4,000 to 6,000 disposable nappies.

This is something that cannot go unnoticed in terms of eco-friendliness, child-friendliness, and household budget. Melu Monkey, the superior eco-brand, knows that well and is ready to introduce a brand new, super comfortable, biodegradable line of baby nappies.

Melu Monkey seamlessly combines the key elements that make its nappies unique and perfect for babies. It is biodegradable and breaks down in a fraction of time compared to regular disposable nappies. The raw materials are ethically sourced from sustainable resources in compliance with the FSC guidelines. The nappies are wrapped in a D2W polybag that biodegrades within 18 months once disposed of.

And there is more. Melu Monkey nappies are predominantly made from bamboo, because of its amazing qualities and sustainability, making them soft & silky to the touch, but also extremely strong & absorbent. Moreover, bamboo is naturally hypoallergenic & antibacterial, making it ideal for those with sensitive skin.

Now, Melu Monkey is creating a powerful crowdfunding campaign to support the production of its amazing nappies, and relative marketing efforts. Potential funders will benefit from lucrative discounts and great perks. They can also show their support by sharing the campaign with their social media networks (Facebook, Instagram, Twitter, LinkedIn, etc.). By becoming more mindful of our daily habits and making environmentally aware choices, we can make a difference (Sir David Attenborough).

For further information and to claim your perk, visit https://www.melumonkey.co.uk

About

Melu Monkey, based in the UK, is launched by Shabnam Ahmed. The brand is inspired by her daughter, Amelia (nicknamed Melu), who is now 4 years old. Its first introduction in the market is the Melu Monkey Eco-Nappies. https://www.melumonkey.co.uk

Share article on social media or email:

RidgeCrest Herbals’ Anxiety Free™ Wins Better Nutrition Magazine’s Best of Supplements Award


News Image

“We are thrilled to have won this award, especially right now as people are looking for ways to manage high levels of anxiety.”

California-based Better Nutrition Magazine has awarded RidgeCrest Herbal’s Anxiety Free™ supplement a Best of Supplements Award in the category of Anxiety, Mood, and Stress. This comes at a moment when tensions are high and many people are dealing with elevated levels of stress and anxiety.

“We are thrilled to have won this award, especially right now as people are looking for ways to manage high levels of anxiety.” says Nichole Petersen, RidgeCrest Herbals’ marketing director. “Many of our employees take Anxiety Free™ themselves, so we know what a positive effect it can have on people’s mood and feelings of well-being.”

Since 2014, RidgeCrest Herbals has won no less than 22 industry awards. Anxiety Free™, a two-time VITY award winner, has been responsible for four of those awards, tying with their ClearLungs© Immune for their most decorated product. Anxiety Free™ is one of RidgeCrest Herbal’s top-selling botanical formulas.

“We can’t thank Better Nutrition Magazine enough for choosing us as a Best of Supplements winner,” says Chris Herbert, Director of Sales. “We feel honored to be included with many other great companies helping consumers stay healthy during these times.”

RidgeCrest Herbals offers Anxiety Free™ to help consumers manage day-to-day stress. It combines vitamins, amino acids, and calming Ayurvedic herbs to help support the body’s natural ability to create feelings of inner peace and deep calm.

Nestled in the shadow of the Wasatch Mountains, Ridgecrest Herbals brings effective, eclectic, innovative botanical blends drawn from ancient global traditions to U.S. consumers. Seller of the #1 selling natural lung product ClearLungs, RidgeCrest Herbals has been helping you “Reach Your Peak” since 1994.

Share article on social media or email:

The Tiny Technology Helping Cannabinoid Balance By CBD Products Inc. Make A Big Splash


Cannabinoid Balance NanoZorb

Nanotechnology has long been understood to support many facets of medical science. Researchers and manufacturers are taking this proven technology and are now applying it to one of the fastest growing consumer markets in the world – CBD. And no one has been more active in bringing this tiny technology to CBD consumers than CBD Products Inc, with their new nano inspired brand Cannabinoid Balance.

Having seen that nanotechnology could have a profound effect on absorption rates in the body, the team at CBD Products Inc. turned to NanoZorb™ to help deliver the cannabinoids and terpenes in their Cannabinoid Balance products into the bloodstream quicker.

As with so many things in science, Nano Technology works by increasing the contact area and in turn increases the rate of absorption. By using NanoZorb™Technology in their Cannabinoid Balance products, Anthony Tribunella realized that he could increase the rate of CBD uptake and make the process of absorption more efficient by bypassing the digestive tract and reducing the CBD degradation that occurs during digestion.

Nano Technology describes the creation of minute particles, so small in fact that millions of them could fit on to just one pinhead. These tiny particles are small enough to be absorbed directly into the bloodstream and delivered to every cell. This means that unlike traditional delivery methods, the constituents being delivered in Cannabinoid Balance’s case get to work as quickly as possible. This makes the product more efficient and therefore more cost-effective per mg.*

It sounds like something out of a Science Fiction movie, but this incredible real-life science is safe, simple, and effective. The NanoZorb™ technology used in Cannabinoid Balance products is developed in an FDA registered facility, so consumers can rest assured that it is safe, effective and often more efficient than products that don’t utilize this incredible technology.*

*The statements and products referred to by Cannabinoid Balance have not been evaluated by the FDA.

CBD Products Inc. is a multi-channel, CBD publishing and retail company established in 2018 that owns and operates cbdproducts.com, cbdworldnews.com and cbdpet.com. In the last year CBD Products Inc. has welcomed more than 25,000 people to their sites and offered information and resources across more than 100,000 page views.

CBD Products Inc. is also the owner of Cannabinoid Balance. A line of consumer products that includes Cannabinoid Balance Original+, Cannabinoid Balance Sleep+, Cannabinoid Balance CBD Gummies+, Cannabinoid Balance Pain Relief Cream and Cannabinoid Balance Pet+. These products are sold via http://www.cbdproducts.com and include proprietary NanoZorb™ Technology designed to make Cannabinoid Balance products more effective and efficient.

It was founded by Anthony Tribunella in 2018. Anthony has worked in all aspects of the industry from growing to production, to publishing and retailing. With more than a decade of experience in CBD and a passion to see the industry become organized and honest, Anthony is rapidly becoming a shining light, thought leader and conscience for the industry he cares so deeply about.

For more information on CBD Products Inc. please visit http://www.cbdproducts.com or email contact@cbdproducts.com.

Share article on social media or email:

Western University of Health Sciences enrollment remains strong amid pandemic


WesternU MSPA students Danielle Poth, left, Gary Rivas and Sean Perez practice the physical assessment checklist under the supervision of PA Assistant Teacher Oscar Norona. (Jeff Malet, WesternU)

“That we welcome so many students again this fall is due to the importance of health care education itself, especially amid a global health crisis, but even more so it is due to our WesternU reputation for academic and clinical excellence,” said WesternU President Daniel R. Wilson, MD, PhD.

Newly-released enrollment figures show Western University of Health Sciences remains a highly-valued destination for students wanting to impact society as health care professionals.

WesternU has an enrollment of 3,816 students for the 2020-21 academic year, an increase from the 2019-20 count of 3,792. The University welcomed more than 1,100 new students in the fall.

“That we welcome so many students again this fall is due to the importance of health care education itself, especially amid a global health crisis, but even more so it is due to our WesternU reputation for academic and clinical excellence — even as University curricula and operations nimbly transitioned to a mostly virtual mode last spring,” said WesternU President Daniel R. Wilson, MD, PhD. “The people involved in this successful transition, and in the successful retention and recruitment of students, are too numerous to mention here by name, but they run the gamut of the University: faculty, deans, administrators, staff, and especially students, all of whom have ‘rolled with the punches’ to ensure that WesternU standards for excellence are met — indeed, are surpassed — despite pandemic-related challenges.”

COVID-19 continues to impact operations on WesternU’s Pomona, California and Lebanon, Oregon campuses. Didactic classes are being held online and prospective students are being interviewed virtually to ensure everyone’s safety. Early data on application rates also show the University is drawing strong interest from prospective students despite all of these COVID-19-related factors.

Applications for the College of Osteopathic Medicine of the Pacific in Pomona and COMP-Northwest in Lebanon are both up compared to the same time last year. COMP has received about 5,500 applications, compared to 4,600 applications one year ago. The College of Optometry’s incoming class has 96 students, far surpassing its goal of 66.

“At WesternU we value prospective students and applicants who are considering our excellent academic programs to achieve their career goals. They are making a major decision and investment and we take very seriously,” said Beverly A. Sanks Guidry, EdD, Senior Vice President for University Student Affairs. “A collaborative approach with our colleges to achieve enrollment success has served us well over the years. We recognize how important every encounter is with each individual — be it digitally or in person. We want applicants who are inspired to attend WesternU and know from our history — that we deliver on our promise to provide a quality educational experience.”

The incoming 2020 class draws students from 40 U.S. states and 22 foreign countries.

“The Admissions team in upholding WesternU’s value of humanism has kept our incoming students at the forefront of the process through caring, respect, empathy and trust,” said Admissions and Enrollment Assistant Vice President Todd Eckel, EdD. “This has enabled us to reach more students on a human level and is reflected in our strong enrollments.”

Share article on social media or email:

AANP Applauds Surgeon General’s Action Plan for Hypertension Control


AANP is the largest organization for NPs of all specialties.

AANP stands with the Surgeon General in calling for NPs and all members of the health care team to work at the top of their profession and expand access to care for hypertensive patients.

The American Association of Nurse Practitioners® (AANP), the largest organization for NPs of all specialties, joins with the U.S. Surgeon General in urging the nation to make hypertension control a priority. With 1 out of 2 adults diagnosed with hypertension, and only 1 in 4 maintaining adequate hypertension control, health professionals and patients must work together to improve outcomes and prevent the costly, devastating impacts of this disease — from heart disease and stroke to cognitive decline, kidney disease and dementia.

“We thank the Surgeon General for focusing our nation on helping patients with hypertension achieve blood pressure control. This silent killer doesn’t just take lives, it undermines the quality of life for millions of patients and drives as much as $198 billion in health care costs each year,” said AANP President Sophia L. Thomas, DNP, APRN, FNP-BC, PPCNP-BC, FNAP, FAANP. “Better health care access can play a significant role in combating the challenge we face, and AANP stands with the Surgeon General in calling for NPs and all members of the health care team to work at the top of their profession and expand access to care for hypertensive patients.”

AANP is committed to working with policymakers, communities, health professionals and health systems to advance the strategies outlined in the Surgeon General’s report, including addressing health care disparities that undermine blood pressure control — from access to high-quality health care and nutritious food to safe spaces for exercise — and empowering and equipping patients as the head of their health care team.

The American Association of Nurse Practitioners® (AANP) is the largest professional membership organization for nurse practitioners (NPs) of all specialties. It represents the interests of the more than 290,000 licensed NPs in the U.S. AANP provides legislative leadership at the local, state and national levels, advancing health policy; promoting excellence in practice, education and research; and establishing standards that best serve NPs’ patients and other health care consumers. As The Voice of the Nurse Practitioner®, AANP represents the interests of NPs as providers of high-quality, cost-effective, comprehensive, patient-centered health care. To locate an NP in your community, visit npfinder.com. For more information about NPs, visit aanp.org. For COVID-19 information from AANP, visit aanp.org/COVID19.

Share article on social media or email:

Noble and Aptar Pharma Launch AdhereIT™, a Connected Medical Device Solution for Disease Management Adherence and Onboarding Patients


Connected medical devices represent the future of healthcare for patients, pharmaceutical companies, health insurers and HCPs, playing a vital role in the remote tracking and treatment of chronic illnesses.

Noble and Aptar Pharma have announced the launch of AdhereIT™ — a connected, intuitive and user-friendly onboarding solution for the growing number of patients with chronic conditions who use autoinjectors to administer their medications at home. AdhereIT™ is the first fully interchangeable, connected add-on solution that can work across a multitude of autoinjector platforms. This launch is an important advancement for Noble, an Aptar Pharma company, whose mission is to foster healthy outcomes for patients who self-administer their therapies, partnering with pharma and biotech companies to provide robust training devices and onboarding programs.

Adherence to prescribed biologics is a significant challenge. A recent report in the Journal of the American Academy of Dermatology reported that 45% of studied patients suffering from psoriasis discontinue their treatments. The reasons include insufficient training or time with an instructor, lack of confidence during the self-injection process, and feelings of high anxiety and lack of control. COVID-19 has contributed to the increase utilization of telemedicine and remote healthcare, which has even further complicated this challenge by reducing healthcare professional (HCP) training opportunities with patients.

AdhereIT™ is part of the digital ecosystem that enables patients to gain control and confidence over their at-home drug delivery while easing the anxiety associated with self- injecting. AdhereIT™ integrates with the existing software applications developed by the Digital Healthcare team at Aptar Pharma by pairing a patient’s autoinjector via Bluetooth technology to their mobile phone. The device — available in two design options to accommodate dexterity for a one-handed or two-handed injection process — precisely detects an injection event and provides real-time visual, audio and haptic feedback about whether the injection was performed correctly. The AdhereIT™ onboarding platform also allows HCPs to monitor their patients’ therapeutic performance via a smart analytical dashboard, providing valuable patient-specific adherence behavior information.

“We are excited to welcome Noble’s AdhereIT™ connected onboarding platform into the suite of Aptar Pharma’s Digital Healthcare solutions. This innovative technology further enhances our ability to improve patients’ lives by creating a seamless integration of injectable products into our disease management offerings,” said Adam Shain, Director of Business Development for Digital Healthcare, Aptar Pharma.

Noble developed AdhereIT™ in partnership with Aptar Pharma, who has made significant investments in digital healthcare over the past three years to actively develop a portfolio of disease management platforms and connected device solutions across dermal, pulmonary, nasal, ophthalmic and injectable routes of administration.

“Connected medical devices represent the future of healthcare for patients, pharmaceutical companies, health insurers and HCPs, playing a vital role in the remote tracking and treatment of chronic illnesses, and delivering a range of benefits that include improved drug management, enriched patient experiences and enhanced patient outcomes,” said Tim McLeroy, Noble’s Executive Director of Marketing & Patient Services. “The connectivity of digital technology solutions like AdhereIT™ also create market differentiation and enable value-based contracting for biopharmaceutical companies and medical device manufacturers to survive in a competitive and challenging marketplace.”

About Noble

Noble is focused on fostering healthy patient outcomes for those who self-administer drug therapies through the development of robust training devices and onboarding solutions for the world’s top pharma brands and biotech companies. Noble manufactures and commercializes training devices that mimic the exact feel, force and function of drug delivery devices such as autoinjectors, prefilled syringes, onbody, nasal and pulmonary devices in order to increase patient adherence and confidence, and decrease usage errors. Noble was founded in 1994 and is based in Orlando, Florida. Noble is an Aptar Pharma company. For more information, visit http://www.gonoble.com.

About Aptar Pharma

Aptar Pharma is part of AptarGroup, Inc., a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active packaging solutions. Aptar uses insights, design, engineering and science to create dosing, dispensing and protective packaging technologies for the world’s leading brands, in turn making a meaningful difference in the lives, looks, health and homes of millions of people around the world. Aptar’s innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, personal care, home, food and beverage. The company is headquartered in Crystal Lake, Illinois and has 14,000 dedicated employees in 20 countries. For more information, visit http://www.aptar.com.

Share article on social media or email:

Protect Our World – Investigation‌ ‌Reveals‌ ‌Unnecessary‌ ‌Student‌ ‌&‌ ‌Worker-Bubble‌ ‌Exposure‌ ‌To‌ ‌COVID


Families, school officials and employers are at the mercy of retail owners & purchasing agents to select and supply effective COVID-specific protection solutions for their local marketplaces. But, convenience stores and price-point brands may not be as concerned with the science behind their products as they are with the immediacy of generating huge profits from uninformed consumers.

Toronto health & safety equipment suppliers Protect Our World announces its breakthrough personal protective equipment (PPE) solution to minimize the risk of COVID-related infections and outbreaks inside and outside of family, school and workplace bubbles – The COVID PROTECTION MASK.

Verified** by Nelson Labs*, a leading provider of laboratory testing and expert advisory services for MedTech and pharmaceutical companies throughout the world, this one-of-a-kind, surgical-grade mask is proven to kill 99.9% of bacteria and viruses that it comes in contact with; and, offers superior protection over N95-rated masks having achieved bacterial kill rate (BFE) and breathability test compliance certifications to ASTM F2102-19 and EN14683:2015 Annex B standards.

“I have a large extended family with many in the most vulnerable COVID risk categories, “ says Senior Product Manager, Charlene Pateropoulos. “This whole pandemic situation raised a lot of questions for us all, especially in regards to children and elderly parents, and answers weren’t coming fast enough. So, I conducted my own investigation and was surprised to discover that some of the best and most affordable protection wasn’t being made available to everyday people. Then, I did something about it — and, here it is, The COVID PROTECTION MASK. It is the only mask of its kind out there and every mom and dad can now move forward with greater confidence and a real feeling of security knowing that The COVID PROTECTION MASK, along with following recommended health and safety guidelines, truly minimizes the risk of the COVID virus infecting those that they care most about”.

Incorporating an exciting leading edge, patented technology based on a proprietary silver ion formula the COVID PROTECTION MASK provides families, friends and coworkers comfort, convenience and over 13 weeks of protection with no loss of effectiveness while providing a responsible and cost effective PPE solution for employers with higher infection-risk workspaces such as factories, schools, hospitals, hotels, retail stores, bars and restaurants.

For more information and/or distribution inquiries, please visit ProtectOurWorld.net. Contact Protect Our World directly by phone (416) 461-1143 or email your inquiries to info@ProtectOurWorld.net.

*Lab Reports:

https://protectourworld.net/wp-content/uploads/2020/10/nelson-labs-1-1.pdf

https://protectourworld.net/wp-content/uploads/2020/10/Nelson-labs-2.pdf

**Funded by MARS Bio-Med Processes Inc.

Share article on social media or email:

PetWellClinic Signs Record 23 Unit Franchise Development Agreement with Multi-Brand Franchise Owner


PetWell Retail Location

The first-mover opportunity is still ripe for the taking in every city across the country and the best way to take advantage of that opportunity is to grow with franchisees that have the ability, know-how, and experience to build and scale businesses quickly.

PetWellClinic announced the signing of a 23 unit franchise development agreement across Southeast Florida this week, awarding the territory to a seasoned multi-unit franchise operator. PetWellClinic is excited about expanding into Florida with a proven franchise developer and his exceptional operations team.

Dr. Sam Meisler, Founder and CEO of PetWellClinic, said, “We’re very lucky to have brought in such a savvy and experienced multi-unit franchise operator at this stage in our development. I think it’s a testament to the potential we all see for PetWell’s growth throughout the country. We look forward to teaching him everything we can about PetWell’s systems, and I’m equally excited to learn from him. I’m confident it will be a mutually beneficial relationship.”

The first location is targeted in Plantation with goals to be open in the first quarter of 2021.

PetWellClinic is a first of its kind walk-in veterinary clinic, providing excellent preventative, wellness, and sick care for dogs and cats on an on-demand basis. There is no need for an appointment and PetWell’s technology, design, and operational systems provide customers with a modern day experience in an antiquated industry.

PetWellClinic recently began franchising after the success of its company owned operations in Knoxville, Tennessee. Its founder and CEO, Dr. Sam Meisler, has practiced veterinary medicine for more than 25 years and worked in just about every type of environment imaginable, from Amish farms to state-of-the-art hospitals. He traces his passion back to his roots, growing up in Africa amongst diverse species of animals, and falling in love with the idea of helping care for them.

With experience in all different types of animals and veterinary practices, including ownership of his own full-service pet hospitals, Dr. Meisler saw an opportunity to get ahead of the curve in what he sees as the future of the industry. He explains it this way:

“I’ve spent 10 years building and refining the systems that now power PetWellClinic franchisees. It wasn’t easy to figure out how to manage operations when you don’t know how many customers are going to walk in at any given hour. We didn’t get everything right in the beginning, and in fact, we got a lot wrong. But I could see our society, especially younger generations, moving toward on-demand services, and so we kept working at it until we got it right. We all expect on-demand convenience these days, and now pet owners can expect it at PetWellClinic.”

He went on to share why he decided to grow PetWellClinic with franchisees, explaining, “I was determined to be the first mover in Knoxville, and I did it successfully. But a couple of years ago, I realized that walk-in veterinary care is still sparse throughout the country, almost non-existent. The first-mover opportunity is still ripe for the taking in every city across the country and the best way to take advantage of that opportunity is to grow with franchisees that have the ability, know-how, and experience to build and scale businesses quickly. Soon we’ll have locations open in Tennessee, New Jersey, Pennsylvania, and Florida.”

For more information on PetWellClinic franchises, please contact Joe Sexton (joseph@oakscale.com).

Share article on social media or email:

WMIS Awards Thomas Meade, PhD, the 2020 Gold Medal Award for Lifetime of Research in Cancer Imaging


Thomas J. Meade, PhD, recipient of the 2020 Gold Medal Award for Lifetime of Research in Cancer Imaging

Thomas J. Meade, PhD, is the recipient of the 2020 Gold Medal Award for Lifetime of Research in Cancer Imaging

It’s wonderful when your curiosity and passion for science can lead to discoveries that can impact people’s lives for the better. At the end of the day, that’s what it’s all about.

The World Molecular Imaging Society (WMIS) awarded the 2020 Gold Medal Award to Thomas J. Meade, PhD, at Northwestern University, for his renowned dedication to the molecular imaging community and revolutionary contributions to the field. Meade accepted the Gold Medal at the 13th annual World Molecular Imaging Congress (WMIC), October 7-9. The meeting was held virtually at wmicvirtual.org. His address in acceptance of the Medal has been postponed to the WMIC annual meeting in Miami, October 6-10 of 2021.

“Meade was chosen for his sustained research in the areas of magnetic resonance and optical molecular imaging, visionary breakthroughs for deep tissue imaging, and advances in quantitative and biologically specific interrogation of living systems,” says Martin Pomper, MD, PhD Director of Nuclear Medicine and Molecular Imaging Johns Hopkins Medicine, Chair of the Awards Committee WMIS.

Currently Meade serves as the Eileen M. Foell Professor of Cancer Research and Professor of Chemistry, Molecular Biosciences, Neurobiology, Biomedical Engineering and Radiology at Northwestern University. He is also a member of the Chemistry of Life Processes Institute (CLP).

Meade is widely recognized as a pioneer in the field of conditionally activated magnetic resonance (MR) agents and the development of probes for MRI and optical imaging. In collaboration with the CLP, he designed the Center for Advanced Molecular Imaging to perform transdisciplinary research from molecule to whole animal. He is the former President and founding member of the Society of Molecular Imaging and founder of Imaging in 2020, a biannual conference focusing on all aspects of imaging. He currently holds over 100 patents and is the founder of companies.

Meade received his master’s in Biochemistry and PhD in inorganic chemistry. After completing a NIH fellowship in Radiology at Harvard Medical School, he was a postdoctoral fellow at the California Institute of Technology. In 1991, he joined the Division of Biology and the Beckman Institute at Caltech. In 2002, Meade moved to Northwestern University, where he is the Director of the Center for Advanced Molecular Imaging (CAMI).

Meade’s research focuses on coordination chemistry and its application in bioinorganic problems that include biological molecular imaging, electron transfer processes and the development of electronic biosensors for the detection of DNA and proteins. He has received numerous awards and in 2009 was a Miller Professor at the University of California Berkeley. Meade holds more than 100 US patents and has founded five biotech companies, Clinical Micro Sensors, Meataprobe, PreDx, Ohmx and DetEctz, which are developing hand-held detection devices for protein and DNA detection and bioactivated MR contrast agents for clinical imaging.

“I am incredibly honored to receive this award,” says Dr. Meade. “It’s wonderful when your curiosity and passion for science can lead to discoveries that can impact people’s lives for the better. At the end of the day, that’s what it’s all about.”

ABOUT WORLD MOLECULAR IMAGING SOCIETY

The WMIS is dedicated to developing and promoting translational research through multimodality molecular imaging. The education and abstract-driven WMIC is the annual meeting of the WMIS and provides a unique setting for scientists and clinicians with very diverse backgrounds to interact, present, and follow cutting-edge advances in the rapidly expanding field of molecular imaging that impacts nearly every biomedical discipline. Industry exhibits at the congress included corporations who have created the latest advances in preclinical and clinical imaging approaches and equipment, providing a complete molecular imaging educational technology showcase. For more information: http://www.wmis.org

Share article on social media or email: